)
)
Otonomy Investor Relations Material
Latest events
Q2 2022
Otonomy
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Otonomy Inc
Access all reports
Otonomy Inc. is a biopharmaceutical company focused on the development of therapeutics for the treatment of ear-related disorders. The company leverages proprietary drug delivery technology to create sustained-exposure formulations designed for conditions such as hearing loss, tinnitus, and otitis media. Otonomy’s pipeline includes both investigational therapies and products aimed at addressing unmet medical needs in otology. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
OTIC
Country
🇺🇸 United States